Skip to content
medxy logo

Medxy AI

  • Specialties
    • Allergy & Immunology
    • Anesthesiology
    • Cardiology
    • Critical Care
    • Dermatology
    • Diabetes & Endocrinology
    • Emergency Medicine
    • Family Medicine & Nutrition
    • Gastroenterology
    • General Surgery
    • Hematology-Oncology
    • HIV/AIDS
    • Infectious Diseases
    • Internal Medicine
    • Nephrology
    • Neurology
    • Nursing & care
    • OB/GYN & Women’s Health
    • Oncology
    • Ophthalmology
    • Orthopedics
    • Otorhinolaryngology
    • Pathology & Lab Medicine
    • Pediatrics
    • Plastic Surgery
    • Psychiatry
    • Public Health
    • Radiology
    • Respiratory
    • Rheumatology
    • Urology
  • Clinical Updates
  • Medical News
  • iDoctor
  • Specialties
    • Allergy & Immunology
    • Anesthesiology
    • Cardiology
    • Critical Care
    • Dermatology
    • Diabetes & Endocrinology
    • Emergency Medicine
    • Family Medicine & Nutrition
    • Gastroenterology
    • General Surgery
    • Hematology-Oncology
    • HIV/AIDS
    • Infectious Diseases
    • Internal Medicine
    • Nephrology
    • Neurology
    • Nursing & care
    • OB/GYN & Women’s Health
    • Oncology
    • Ophthalmology
    • Orthopedics
    • Otorhinolaryngology
    • Pathology & Lab Medicine
    • Pediatrics
    • Plastic Surgery
    • Psychiatry
    • Public Health
    • Radiology
    • Respiratory
    • Rheumatology
    • Urology
  • Clinical Updates
  • Medical News
  • iDoctor
  • facebook.com
  • twitter.com
  • t.me
  • instagram.com
  • youtube.com
Subscribe
Community-Centered Education Improves Clinical Trial Knowledge and Self-Efficacy Among Minoritized Women
Posted innews Oncology

Community-Centered Education Improves Clinical Trial Knowledge and Self-Efficacy Among Minoritized Women

Posted by MedXY By MedXY 04/26/2026
A culturally tailored educational intervention significantly improved clinical trial knowledge and self-efficacy among African American and Hispanic women, highlighting the potential of community partnerships to address disparities in gynecologic cancer research participation.
Read More
Optimizing Delivery Timing for Obese Pregnancies: The Critical Role of Pre-Pregnancy Diabetes in Stillbirth Risk
Posted innews

Optimizing Delivery Timing for Obese Pregnancies: The Critical Role of Pre-Pregnancy Diabetes in Stillbirth Risk

Posted by MedXY By MedXY 04/26/2026
A nationwide study reveals that pre-pregnancy BMI and diabetes status significantly influence gestational age-specific stillbirth risks, with obese diabetic women facing the highest absolute risks, necessitating tailored delivery timing strategies.
Read More
ACOG Endorses Updated 2026 Cervical Cancer Screening Guidelines: Key Changes and Implications
Posted innews Oncology

ACOG Endorses Updated 2026 Cervical Cancer Screening Guidelines: Key Changes and Implications

Posted by MedXY By MedXY 04/26/2026
The American College of Obstetricians and Gynecologists (ACOG) has qualifiedly endorsed the 2026 WPSI cervical cancer screening guidelines. This article details the core recommendations, highlights key updates including self-collection options, and explores expert perspectives on implementation.
Read More
Combination Therapy with GLP-1 Receptor Agonists and SGLT-2 Inhibitors Reduces Liver and Cardiovascular Risks in MASLD and Type 2 Diabetes
Posted inDiabetes & Endocrinology Gastroenterology news

Combination Therapy with GLP-1 Receptor Agonists and SGLT-2 Inhibitors Reduces Liver and Cardiovascular Risks in MASLD and Type 2 Diabetes

Posted by MedXY By MedXY 04/25/2026
A study reveals that combining GLP-1 receptor agonists with SGLT-2 inhibitors significantly lowers the risk of major adverse liver and cardiovascular outcomes in patients with MASLD and type 2 diabetes compared to monotherapy.
Read More
CD16+ γδ T Cells: A Novel Player in HBV Viral Control Through Antibody-Dependent Cytotoxicity
Posted inGastroenterology Infectious Diseases news

CD16+ γδ T Cells: A Novel Player in HBV Viral Control Through Antibody-Dependent Cytotoxicity

Posted by MedXY By MedXY 04/25/2026
A study reveals CD16+ γδ T cells as key mediators of antibody-dependent cellular cytotoxicity in HBV infection, correlating with reduced viral replication and offering new therapeutic targets.
Read More
Clonal Lymphocyte Expansions and JAK-STAT Mutations Drive Refractory Celiac Disease
Posted inGastroenterology Hematology-Oncology news

Clonal Lymphocyte Expansions and JAK-STAT Mutations Drive Refractory Celiac Disease

Posted by MedXY By MedXY 04/25/2026
This study uncovers clonal lymphocyte expansions and JAK-STAT pathway mutations as key drivers of refractory celiac disease, suggesting a shared pathogenic continuum between RCD1 and RCD2 while cautioning against JAK inhibitor monotherapy due to resistance risks.
Read More
EVT Shows Superior Outcomes in Anterior Cerebral Artery Occlusion Stroke: Insights from the ORIENTAL-MeVO Registry
Posted inNeurology news

EVT Shows Superior Outcomes in Anterior Cerebral Artery Occlusion Stroke: Insights from the ORIENTAL-MeVO Registry

Posted by MedXY By MedXY 04/25/2026
Endovascular thrombectomy (EVT) significantly improves 90-day functional outcomes in acute anterior cerebral artery occlusion stroke compared to standard medical management, without increasing hemorrhage or mortality risks, per the ORIENTAL-MeVO Registry.
Read More
Optimal Sleep Duration Mitigates Cognitive Decline and Dementia Risk in Focal Epilepsy: Insights from the UK Biobank Study
Posted inNeurology news

Optimal Sleep Duration Mitigates Cognitive Decline and Dementia Risk in Focal Epilepsy: Insights from the UK Biobank Study

Posted by MedXY By MedXY 04/25/2026
A UK Biobank study reveals that optimal sleep (6-8 hours) improves executive function and reduces dementia risk in focal epilepsy patients, with effects surpassing those in stroke patients. Nonoptimal sleep exacerbates cognitive deficits up to 8 years pre-diagnosis.
Read More
uGMI: A More Accurate Alternative to HbA1c for Diabetes Management
Posted inDiabetes & Endocrinology news

uGMI: A More Accurate Alternative to HbA1c for Diabetes Management

Posted by MedXY By MedXY 04/24/2026
The updated glucose management indicator (uGMI) significantly improves alignment with HbA1c, reducing discordance, particularly in high and low glucose ranges, offering clinicians a more reliable tool for diabetes monitoring.
Read More
Advancing Personalized Treatment in Papillary Thyroid Cancer: A Machine-Learning Model for Predicting Occult Lymph Node Metastasis
Posted innews Oncology

Advancing Personalized Treatment in Papillary Thyroid Cancer: A Machine-Learning Model for Predicting Occult Lymph Node Metastasis

Posted by MedXY By MedXY 04/24/2026
A novel machine-learning model incorporating clinical, ultrasonographic, and molecular features predicts occult central lymph node metastasis in papillary thyroid cancer, with RET fusion positivity identified as a key risk factor.
Read More
Long-term Air Pollution Linked to Adverse Body Composition Changes in Older Adults with Metabolic Syndrome
Posted inDiabetes & Endocrinology news Public Health

Long-term Air Pollution Linked to Adverse Body Composition Changes in Older Adults with Metabolic Syndrome

Posted by MedXY By MedXY 04/24/2026
A study of 1,454 older adults with metabolic syndrome reveals that long-term exposure to air pollutants like black carbon, PM2.5, and NO2 is associated with increased fat mass and decreased lean mass, persisting over three years, particularly in those under 65.
Read More
Bradykinin’s Modest Role in Sacubitril/Valsartan’s Blood Pressure Effects Revealed
Posted inCardiology news

Bradykinin’s Modest Role in Sacubitril/Valsartan’s Blood Pressure Effects Revealed

Posted by MedXY By MedXY 04/24/2026
A study finds bradykinin modestly contributes to blood pressure reduction with sacubitril/valsartan in chronic heart failure, highlighting ANP's role in initial effects and bradykinin's influence during chronic therapy.
Read More
Revolutionary Sixth-Generation Troponin Assay Doubles Early MI Rule-Out Capacity
Posted inCardiology Emergency Medicine news

Revolutionary Sixth-Generation Troponin Assay Doubles Early MI Rule-Out Capacity

Posted by MedXY By MedXY 04/24/2026
A novel sixth-gen hs-cTnT assay with a 13 ng/L threshold safely identified twice as many low-risk MI patients at ED presentation vs fifth-gen assays, achieving >99.5% NPV in multinational validation.
Read More
Blocking P2Y14R Emerges to Combat Venous Thromboembolism via Neutrophil-Plaque Interaction
Posted inCardiology Hematology-Oncology news

Blocking P2Y14R Emerges to Combat Venous Thromboembolism via Neutrophil-Plaque Interaction

Posted by MedXY By MedXY 04/24/2026
New research identifies P2Y14R as a key regulator of neutrophil-platelet aggregates and NET formation in venous thrombosis, with proglumide showing promise as a therapeutic antagonist.
Read More
Left Bundle Branch Pacing Outperforms Traditional Pacing in High-Risk Cardiac Patients
Posted inCardiology news

Left Bundle Branch Pacing Outperforms Traditional Pacing in High-Risk Cardiac Patients

Posted by MedXY By MedXY 04/24/2026
A randomized trial shows left bundle branch pacing significantly reduces the risk of pacing-induced cardiomyopathy and improves cardiac function compared to right ventricular pacing in high-risk patients.
Read More
Pediatric Hypertrophic Cardiomyopathy: The High-Risk Profile of Massive Left Ventricular Hypertrophy
Posted inCardiology news Pediatrics

Pediatric Hypertrophic Cardiomyopathy: The High-Risk Profile of Massive Left Ventricular Hypertrophy

Posted by MedXY By MedXY 04/24/2026
A multiregistry analysis reveals that massive LVH in pediatric HCM is linked to early diagnosis, sarcomeric mutations, and heightened risks of arrhythmias, heart failure, and mortality. Nearly 25% of patients show significant LVH regression over time.
Read More
2/20/20 Model Outperforms AQUILA Criteria in Identifying High-Risk Smoldering Multiple Myeloma
Posted inHematology-Oncology news

2/20/20 Model Outperforms AQUILA Criteria in Identifying High-Risk Smoldering Multiple Myeloma

Posted by MedXY By MedXY 04/24/2026
The 2/20/20 risk stratification model identifies a smaller, truly high-risk SMM group with higher progression rates than the AQUILA trial criteria, suggesting better targeting for early intervention.
Read More
Cultural Diversity in ICU: A Protective Factor Against Sepsis Mortality
Posted inCritical Care Infectious Diseases news

Cultural Diversity in ICU: A Protective Factor Against Sepsis Mortality

Posted by MedXY By MedXY 04/24/2026
A multicenter study reveals that culturally and linguistically diverse patients with sepsis had lower in-hospital mortality and shorter ICU stays compared to non-CaLD patients, challenging prior assumptions about healthcare disparities.
Read More
LEGEND Trial: A Game-Changer in Rapid Rule-Out of Acute Myocardial Infarction in the ED
Posted inCardiology Emergency Medicine news

LEGEND Trial: A Game-Changer in Rapid Rule-Out of Acute Myocardial Infarction in the ED

Posted by MedXY By MedXY 04/24/2026
The LEGEND trial demonstrates that a high-sensitivity troponin-based rule-out strategy significantly reduces hospital length of stay and cardiac testing while safely excluding acute myocardial infarction in emergency department patients.
Read More
Video Declarations: Bridging the Gap in Advanced Cancer Care Conversations
Posted inInternal Medicine news Oncology

Video Declarations: Bridging the Gap in Advanced Cancer Care Conversations

Posted by MedXY By MedXY 04/24/2026
A study explores how video declarations from advanced cancer patients can enhance goals of care discussions by focusing on decision-making factors rather than specific medical interventions, offering a patient-centered tool for advance care planning.
Read More

Posts pagination

Previous page 1 … 4 5 6 7 8 … 243 Next page
  • Epigenetic Regulation of Myocardial Inflammation: The Role of Macrophage PRMT9 and STAT1 Degradation in Acute Myocardial Infarction
  • Semaglutide Reduced Effort Discounting and Improved Motivation Signals in Major Depressive Disorder
  • Continuous Subphenotype Probabilities Expose High-Risk Patients Hidden Within “Hypoinflammatory” Acute Respiratory Failure
  • Earlier Mechanical Thrombectomy for Intermediate-Risk Pulmonary Embolism Improves Hemodynamics but Not In-Hospital Mortality
  • Ambient AI Scribes Reduced Emergency Department Documentation Time, but Early Adoption Was Limited and Highly Concentrated
Post You Might Like
Posted inClinical Updates news
Epigenetic Regulation of Myocardial Inflammation: The Role of Macrophage PRMT9 and STAT1 Degradation in Acute Myocardial Infarction
Posted by MedXY By MedXY 05/05/2026
Posted inDiabetes & Endocrinology news Psychiatry
Semaglutide Reduced Effort Discounting and Improved Motivation Signals in Major Depressive Disorder
Posted by MedXY By MedXY 05/05/2026
Posted inCritical Care news Respiratory
Continuous Subphenotype Probabilities Expose High-Risk Patients Hidden Within “Hypoinflammatory” Acute Respiratory Failure
Posted by MedXY By MedXY 05/05/2026
Posted inCardiology Critical Care news
Earlier Mechanical Thrombectomy for Intermediate-Risk Pulmonary Embolism Improves Hemodynamics but Not In-Hospital Mortality
Posted by MedXY By MedXY 05/05/2026
  • About us
  • Contact us
  • MedXY story
  • Privacy Policy
  • Subscribe Now!
  • 账号

  • English
  • 日本語
  • Tiếng Việt
  • 中文

Alzheimer's disease artificial intelligence atrial fibrillation biomarkers breast cancer Cardiology cardiovascular disease cardiovascular risk chronic kidney disease clinical trial clinical trials critical care depression diabetes epidemiology health heart failure Hypertension immunotherapy inflammation MASLD mental health metformin Mortality myocardial infarction nutrition obesity older adults oncology Pediatrics precision medicine Pregnancy prevention prostate cancer public health randomized clinical trial randomized trial risk stratification SGLT2 inhibitors stroke targeted therapy type 1 diabetes type 2 diabetes weight loss women's health

Your health, we care

Copyright 2026 — Medxy AI. All rights reserved.
Scroll to Top
Sign in